Clinical Research Services
Accredited Services. Cutting-edge Sequencing.
ArcherDX Clinical Sequencing Services is performed at our wholly owned subsidiary, ArcherDX Clinical Services, Inc., which is a CLIA (Clinical Laboratory Improvements Amendment)-certified and CAP (College of American Pathologists)-accredited Clinical Services Laboratory. We offer a wide variety of services for researchers, clinicians, and life science partners.
Our results are generated using an analytically validated process consistent with laboratory developed tests. It has not been cleared or approved by the U.S. Food and Drug Administration.
We provide next-generation sequencing (NGS) services and tests that are cutting-edge – both CLIA-certified and CAP-accredited.
Use ArcherDX to target cancer’s deepest vulnerabilities
Clinical Sequencing Services
- Tumor profiling
- Immune profiling
- Minimal residual disease testing
- Viral integration
Research Support Services
- Analyte Extraction: DNA, RNA, TNA, ctDNA
- Library Preparation
- Next-generation sequencing (NGS): Illumina®
- Bioinformatics Support
- Validation Support
Patients will not receive medical results, a diagnosis, or a recommendation for treatment from ArcherDX. If any questions or concerns arise about what is learned through this sequencing information, patients should contact their treating physician or a genetic counselor.